Bioorganic and Medicinal Chemistry Letters p. 4501 - 4505 (2013)
Update date:2022-08-03
Topics:
Gangloff, Anthony R.
Brown, Jason
De Jong, Ron
Dougan, Douglas R.
Grimshaw, Charles E.
Hixon, Mark
Jennings, Andy
Kamran, Ruhi
Kiryanov, Andre
O'Connell, Shawn
Taylor, Ewan
Vu, Phong
Structure based drug design of a series of novel 1,4-benzoxazin-3-one derived PARP-1 inhibitors are described. The synthesis, enzymatic & cellular activities and pharmacodynamic effects are described. Optimized analogs demonstrated inhibition of poly-ADP-ribosylation in SW620 tumor bearing nude mice through 24 h following a single dose.
View MoreZibo Fuxi'er Chemical Co.,Ltd (Shanxian Fuxi'er Chemical Co.,Ltd)
Contact:+86-533-2091422
Address:Eastern 4 on the 3th Road ,Liangxiang Industrial Park, Zibo city ,Shandong,China
Jinan Baozhao Pharmaceutical Co., Ltd
Contact:0086-531-86397156 82371858 82371868
Address:Huaneng Road, Jinan, Shandong ,China
Contact:86-571-86737118-8689
Address:No.69, 12 Street, HEDA, Hangzhou, Zhejiang, China
ZHANGJIAGANG FREE TRADE ZONE YONG HAN INTERNATIONAL TRADING CO., LTD(expird)
Contact:86 512 57910558
Address:qianjin M road
Jinan Decheng Hemu Medical Technology Co.,Ltd.
Contact:+86-531-68650525
Address:NO.554 Zhengfeng Road High-new Technology Development Zone
Doi:10.1021/jo026295b
(2002)Doi:10.1016/S0040-4039(02)01831-2
(2002)Doi:10.1021/ja012518o
(2002)Doi:10.1016/0040-4020(73)80249-2
(1973)Doi:10.3390/molecules22111925
(2017)Doi:10.1021/ja01161a051
(1950)